
John D. Ulm
Examiner (ID: 10769, Phone: (571)272-0880 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1812, 1646, 1805 |
| Total Applications | 2240 |
| Issued Applications | 1195 |
| Pending Applications | 205 |
| Abandoned Applications | 843 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8059761
[patent_doc_number] => 20120079613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity'
[patent_app_type] => utility
[patent_app_number] => 12/296814
[patent_app_country] => US
[patent_app_date] => 2007-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14122
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20120079613.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296814
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296814 | Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity | Apr 1, 2007 | Abandoned |
Array
(
[id] => 6423594
[patent_doc_number] => 20100168003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Agent for Treating Polyglutamine Aggregation-Caused Disease or Suppressing Onset Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/226447
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17452
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168003.pdf
[firstpage_image] =>[orig_patent_app_number] => 12226447
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/226447 | Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof | Mar 29, 2007 | Issued |
Array
(
[id] => 5091692
[patent_doc_number] => 20070231331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER\'S DISEASE AND IMPROVING NORMAL MEMORY'
[patent_app_type] => utility
[patent_app_number] => 11/693926
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22119
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231331.pdf
[firstpage_image] =>[orig_patent_app_number] => 11693926
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/693926 | Methods for screening agents that modulate presenilin activity and A-β production | Mar 29, 2007 | Issued |
Array
(
[id] => 5279505
[patent_doc_number] => 20090131637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Vanilloid receptor'
[patent_app_type] => utility
[patent_app_number] => 11/716476
[patent_app_country] => US
[patent_app_date] => 2007-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2753
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131637.pdf
[firstpage_image] =>[orig_patent_app_number] => 11716476
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/716476 | Vanilloid receptor | Mar 8, 2007 | Abandoned |
Array
(
[id] => 4445381
[patent_doc_number] => 07863433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-04
[patent_title] => 'Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction'
[patent_app_type] => utility
[patent_app_number] => 11/716362
[patent_app_country] => US
[patent_app_date] => 2007-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23058
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/863/07863433.pdf
[firstpage_image] =>[orig_patent_app_number] => 11716362
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/716362 | Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction | Mar 7, 2007 | Issued |
Array
(
[id] => 4688136
[patent_doc_number] => 20080032317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'Methods for improving the function of heterlogous G protein-coupled receptors'
[patent_app_type] => utility
[patent_app_number] => 11/708333
[patent_app_country] => US
[patent_app_date] => 2007-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7703
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20080032317.pdf
[firstpage_image] =>[orig_patent_app_number] => 11708333
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/708333 | Methods for improving the function of heterlogous G protein-coupled receptors | Feb 20, 2007 | Abandoned |
Array
(
[id] => 5005003
[patent_doc_number] => 20070202573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Soluble fusion proteins comprising heterologous polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/705106
[patent_app_country] => US
[patent_app_date] => 2007-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 26896
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202573.pdf
[firstpage_image] =>[orig_patent_app_number] => 11705106
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/705106 | Soluble fusion proteins comprising heterologous polypeptides | Feb 11, 2007 | Issued |
Array
(
[id] => 5112958
[patent_doc_number] => 20070196873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Pain signaling molecules'
[patent_app_type] => utility
[patent_app_number] => 11/703062
[patent_app_country] => US
[patent_app_date] => 2007-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 39115
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20070196873.pdf
[firstpage_image] =>[orig_patent_app_number] => 11703062
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/703062 | Pain signaling molecules | Feb 4, 2007 | Issued |
Array
(
[id] => 170260
[patent_doc_number] => 07662574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Use of a G protein-coupled receptor and its cognizant ligand in the identification of compounds that affect prolactin secretion'
[patent_app_type] => utility
[patent_app_number] => 11/701719
[patent_app_country] => US
[patent_app_date] => 2007-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 65815
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 339
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662574.pdf
[firstpage_image] =>[orig_patent_app_number] => 11701719
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/701719 | Use of a G protein-coupled receptor and its cognizant ligand in the identification of compounds that affect prolactin secretion | Feb 1, 2007 | Issued |
Array
(
[id] => 6465026
[patent_doc_number] => 20100190698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'Neuroprotective peptide inhibitors of AP-1 signaling and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 12/441695
[patent_app_country] => US
[patent_app_date] => 2007-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 25575
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190698.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441695
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441695 | Neuroprotective peptide inhibitors of AP-1 signaling and uses therefor | Jan 30, 2007 | Issued |
Array
(
[id] => 6120874
[patent_doc_number] => 20110077204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'Agent for Targeted Drug Delivery To Cerebral Neurons'
[patent_app_type] => utility
[patent_app_number] => 12/223113
[patent_app_country] => US
[patent_app_date] => 2007-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7734
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077204.pdf
[firstpage_image] =>[orig_patent_app_number] => 12223113
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/223113 | Agent for Targeted Drug Delivery To Cerebral Neurons | Jan 23, 2007 | Abandoned |
Array
(
[id] => 5101228
[patent_doc_number] => 20070184490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Neuronal nicotinic receptor ligands and their use'
[patent_app_type] => utility
[patent_app_number] => 11/653553
[patent_app_country] => US
[patent_app_date] => 2007-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12339
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20070184490.pdf
[firstpage_image] =>[orig_patent_app_number] => 11653553
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/653553 | Neuronal nicotinic receptor ligands and their use | Jan 15, 2007 | Abandoned |
Array
(
[id] => 5095529
[patent_doc_number] => 20070117138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'SPLICE VARIANT CANNABINOID RECEPTOR (CB1B)'
[patent_app_type] => utility
[patent_app_number] => 11/622220
[patent_app_country] => US
[patent_app_date] => 2007-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8412
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117138.pdf
[firstpage_image] =>[orig_patent_app_number] => 11622220
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/622220 | SPLICE VARIANT CANNABINOID RECEPTOR (CB1B) | Jan 10, 2007 | Abandoned |
Array
(
[id] => 288910
[patent_doc_number] => 07547523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-16
[patent_title] => 'Histamine receptor'
[patent_app_type] => utility
[patent_app_number] => 11/620337
[patent_app_country] => US
[patent_app_date] => 2007-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14711
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 266
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/547/07547523.pdf
[firstpage_image] =>[orig_patent_app_number] => 11620337
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/620337 | Histamine receptor | Jan 4, 2007 | Issued |
Array
(
[id] => 7691495
[patent_doc_number] => 20070232538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Uses of polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/647076
[patent_app_country] => US
[patent_app_date] => 2006-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 80869
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232538.pdf
[firstpage_image] =>[orig_patent_app_number] => 11647076
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/647076 | Uses of polypeptides | Dec 26, 2006 | Abandoned |
Array
(
[id] => 330352
[patent_doc_number] => 07510847
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-31
[patent_title] => 'Kidney-specific urate transporter and gene thereof'
[patent_app_type] => utility
[patent_app_number] => 11/644193
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5049
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/510/07510847.pdf
[firstpage_image] =>[orig_patent_app_number] => 11644193
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/644193 | Kidney-specific urate transporter and gene thereof | Dec 20, 2006 | Issued |
Array
(
[id] => 5435540
[patent_doc_number] => 20090170127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'Screening Compounds for Activity in Modulating Chloride Ion Transport'
[patent_app_type] => utility
[patent_app_number] => 12/086726
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10176
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170127.pdf
[firstpage_image] =>[orig_patent_app_number] => 12086726
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086726 | Screening compounds for activity in modulating chloride ion transport | Dec 17, 2006 | Issued |
Array
(
[id] => 6477318
[patent_doc_number] => 20100285045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Novel Neurotrophic Factor Protein and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/086397
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 34538
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285045.pdf
[firstpage_image] =>[orig_patent_app_number] => 12086397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086397 | Novel Neurotrophic Factor Protein and Uses Thereof | Dec 13, 2006 | Abandoned |
Array
(
[id] => 4745279
[patent_doc_number] => 20080089881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Treatment and Diagnostics of Inflammatory Diseases'
[patent_app_type] => utility
[patent_app_number] => 11/567341
[patent_app_country] => US
[patent_app_date] => 2006-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5228
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20080089881.pdf
[firstpage_image] =>[orig_patent_app_number] => 11567341
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/567341 | Treatment and Diagnostics of Inflammatory Diseases | Dec 5, 2006 | Abandoned |
Array
(
[id] => 5107039
[patent_doc_number] => 20070065917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Endogenous and non-endogenous, constitutively activated human G protein-coupled receptions'
[patent_app_type] => utility
[patent_app_number] => 11/603386
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19088
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065917.pdf
[firstpage_image] =>[orig_patent_app_number] => 11603386
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/603386 | Endogenous and non-endogenous, constitutively activated human G protein-coupled receptions | Nov 21, 2006 | Abandoned |